Tau-induced neurodegeneration: mechanisms and targets

+ 作者地址

  • 参考文献
  • 相关文章
  • 统计

[10] Morais VA;De Strooper B .Mitochondria dysfunction and neurodegenerative disorders: cause or consequence.[J].Journal of Alzheimer's disease,2010(suppl.2):S255-263.

[13] Goux WJ;Rodriguez S;Sparkman DR .Characterization of the glycolipid associated with Alzheimer paired helical filaments.[J].Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry,1996(2):723-733.

[17] Ballatore C;Lee VM;Trojanowski JQ .Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.[J].Nature reviews neuroscience,2007(9):663-672.

[18] Lee,VM;Goedert,M;Trojanowski,JQ .Neurodegenerative tauopathies.[J].Annual Review of Neuroscience,2001(0):1121-1159.

[19] Wimo,A.;J?nsson,L.;Bond,J.;Prince,M.;Winblad,B. .The worldwide economic impact of dementia 2010[J].Alzheimer’s & dementia: the journal of the Alzheimer’s Association,2013(1):1-11.

[20] Liu Fei;Gong Cheng Xin;Alonso Alejandra Del C;Grundke Iqbal Inge .Mechanisms of tau-induced neurodegeneration.[J].Acta Neuropathologica,2009(1):53-69.

[21] McKee AC;Cantu RC;Nowinski CJ .Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.[J].Journal of Neuropathology and Experimental Neurology,2009(7):709-735.

[22] Small,G.W.;Kepe,V.;Siddarth,P.;Ercoli,L.M.;Merrill,D.A.;Donoghue,N.;Bookheimer,S.Y.;Martinez,J.;Omalu,B.;Bailes,J.;Barrio,J.R. .PET scanning of brain tau in retired national football league players: Preliminary findings[J].The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry,2013(2):138-144.

[23] Luc Buee;Laetitia Troquier Sylvie Burnouf;Karim Belarbi;Anneke Van der Jeugd;Tariq Ahmed .From tau phosphorylation to tau aggregation: what about neuronal death?[J].Biochemical Society Transactions,2010(4):967-972.

[24] Stoothoff WH;Johnson GVW .Tau phosphorylation: physiological and pathological consequences[J].Biochimica et biophysica acta. Molecular basis of disease: BBA,2005(2/3):280-297.

[28] Wang,J.-Z.;Xia,Y.-Y.;Grundke-Iqbal,I.;Iqbal,K. .Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration[J].Journal of Alzheimer's disease: JAD,2013(Suppl.1):S123-S139.

[29] Alonso- A;Zaidi T;Novak M;Grundke-Iqbal I;Iqbal K .Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.[J].Proceedings of the National Academy of Sciences of the United States of America,2001(12):6923-6928.

[33] Utton MA;Vandecandelaere A;Wagner U;Reynolds CH;Gibb GM;Miller CCJ;Bayley PM;Anderton BH; .Phosphorylation of tau by glycogen synthase kinase 3 beta affects the ability of tau to promote microtubule self-assembly[J].The Biochemical Journal,1997(Pt.3):741-747.

[34] Li G;Yin H;Kuret J .Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.[J].The Journal of biological chemistry,2004(16):15938-15945.

[35] Zhu LQ;Wang SH;Liu D;Yin YY;Tian Q;Wang XC;Wang Q;Chen JG;Wang JZ .Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments.[J].The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,2007(45):12211-12220.

[36] Zhu LQ;Liu D;Hu .GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation.[J].The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,2010(10):3624-3633.

[37] Li,X.-H.;Lv,B.-L.;Xie,J.-Z.;Liu,J.;Zhou,X.-W.;Wang,J.-Z. .AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation[J].Neurobiology of Aging: Experimental and Clinical Research,2012(7):1400-1410.

[38] Peng,C.-X.;Hu,J.;Liu,D.;Hong,X.-P.;Wu,Y.-Y.;Zhu,L.-Q.;Wang,J.-Z. .Disease-modified glycogen synthase kinase-3β intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model[J].Neurobiology of Aging: Experimental and Clinical Research,2013(6):1555-1563.

[39] Smith DS;Tsai LH .Cdk5 behind the wheel: a role in trafficking and transport? [Review][J].Trends in Cell Biology,2002(1):28-36.

[40] Hamdane M;Sambo AV;Delobel P;Begard S;Violleau A;Delacourte A;Bertrand P;Benavides J;Buee L .Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex.[J].The Journal of biological chemistry,2003(36):34026-34034.

[41] Marx A;Nugoor C;Panneerselvam S;Mandelkow E .Structure and function of polarity-inducing kinase family MARK/Par-1 within the branch of AMPK/Snf1-related kinases.[J].The FASEB Journal,2010(6):1637-1648.

[44] Chatterjee S;Sang TK;Lawless GM;Jackson GR .Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.[J].Human Molecular Genetics,2009(1):164-177.

[47] Liu F;Iqbal K;Grundke Iqbal I;Hart GW;Gong CX .O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.[J].Proceedings of the National Academy of Sciences of the United States of America,2004(29):10804-10809.

[49] Sontag E;Nunbhakdi Craig-V;Lee G;Brandt R;Kamibayashi C;Kuret J;White CL-3rd;Mumby MC;Bloom GS .Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.[J].The Journal of biological chemistry,1999(36):25490-25498.

[50] Liu GP;Zhang Y;Yao XQ;Zhang CE;Fang J;Wang Q;Wang JZ .Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms.[J].Neurobiology of Aging: Experimental and Clinical Research,2008(9):1348-1358.

[51] Qian W;Shi J;Yin X;Iqbal K;Grundke Iqbal I;Gong CX;Liu F .PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.[J].Journal of Alzheimer's disease,2010(4):1221-1229.

[52] Sun,X.-Y.;Wei,Y.-P.;Xiong,Y.;Wang,X.-C.;Xie,A.-J.;Wang,X.-L.;Yang,Y.;Wang,Q.;Lu,Y.-M.;Liu,R.;Wang,J.-Z. .Synaptic released zinc promotes tau hyperphosphorylation by inhibition of Protein Phosphatase 2A (PP2A)[J].The Journal of biological chemistry,2012(14):11174-11182.

[53] Xiong,Y.;Jing,X.-P.;Zhou,X.-W.;Wang,X.-L.;Yang,Y.;Sun,X.-Y.;Qiu,M.;Cao,F.-Y.;Lu,Y.-M.;Liu,R.;Wang,J.-Z. .Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation[J].Neurobiology of Aging: Experimental and Clinical Research,2013(3):745-756.

[54] Nayeem N;Kerr F;Naumann H;Linehan J;Lovestone S;Brandner S .Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella[J].Molecular and cellular neurosciences,2007(3):400-408.

[55] Tremblay MA;Acker CM;Davies P .Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.[J].Journal of Alzheimer's disease,2010(2):721-733.

[56] Bhaskar K;Hobbs GA;Yen SH;Lee G .Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.[J].Neuropathology and applied neurobiology,2010(6):462-477.

[59] Riederer,B.M.;Leuba,G.;ElHajj,Z. .Oxidation and ubiquitination in neurodegeneration[J].Experimental Biology and Medicine: Journal of the Society for Experimental Biology and Medicine,2013(5):519-524.

[60] Li,J.;Liu,D.;Sun,L.;Lu,Y.;Zhang,Z. .Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective[J].Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology,2012(1/2):1-5.

[62] Reyes JF;Fu Y;Vana L;Kanaan NM;Binder LI .Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease.[J].American Journal of Pathology: Official Publication of the American Association of Pathologists,2011(5):2275-2285.

[63] Martin L;Latypova X;Terro F .Post-translational modifications of tau protein: implications for Alzheimer's disease.[J].Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry,2011(4):458-471.

[65] Thomas,S.N.;Funk,K.E.;Wan,Y.;Liao,Z.;Davies,P.;Kuret,J.;Yang,A.J. .Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: A mass spectrometry approach[J].Acta Neuropathologica,2012(1):105-117.

[66] Min SW;Cho SH;Zhou Y;Schroeder S;Haroutunian V;Seeley WW;Huang EJ;Shen Y;Masliah E;Mukherjee C;Meyers D;Cole PA;Ott M;Gan L .Acetylation of tau inhibits its degradation and contributes to tauopathy.[J].Neuron,2010(6):953-966.

[67] Cook,C.;Gendron,T.F.;Scheffel,K.;Carlomagno,Y.;Dunmore,J.;DeTure,M.;Petrucelli,L. .Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation[J].Human Molecular Genetics,2012(13):2936-2945.

[68] Zhang,L.;Sheng,S.;Qin,C. .The role of HDAC6 in Alzheimer's disease[J].Journal of Alzheimer's disease: JAD,2013(2):283-295.

[69] Cook,C.;Carlomagno,Y.;Gendron,T.F.;Dunmore,J.;Scheffel,K.;Stetler,C.;Davis,M.;Dickson,D.;Jarpe,M.;DeTure,M.;Petrucelli,L. .Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance[J].Human Molecular Genetics,2014(1):104-116.

[70] Choi H;Fermin D;Nesvizhskii AI .Significance Analysis of Spectral Count Data in Label-free Shotgun Proteomics.[J].Molecular & cellular proteomics: MCP,2008(12):2373-2385.

[71] Liu Y;Liu F;Grundke Iqbal .Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.[J].Journal of Neurochemistry,2009(1):242-249.

[72] Yuzwa, S.A.;Shan, X.;MacAuley, M.S.;Clark, T.;Skorobogatko, Y.;Vosseller, K.;Vocadlo, D.J. .Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation[J].Nature chemical biology,2012(4):393-399.

[74] Lee,L.;Sakurai,M.;Matsuzaki,S.;Arancio,O.;Fraser,P. .SUMO and alzheimer's disease[J].Neuromolecular medicine,2013(4):720-736.

[76] Goedert M;Jakes R;Spillantini MG;Hasegawa M;Smith MJ;Crowther RA .Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.[J].Nature,1996(6600):550-553.

[77] Chen H;Chan DC .Critical dependence of neurons on mitochondrial dynamics.[J].Current Opinion in Cell Biology,2006(4):453-459.

[78] Wang X;Su B;Lee HG .Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.[J].The Journal of Neuroscience,2009(28):9090-9103.

[79] Su B;Wang X;Zheng L;Perry G;Smith MA;Zhu X .Abnormal mitochondrial dynamics and neurodegenerative diseases.[J].Biochimica et biophysica acta. Molecular basis of disease: BBA,2010(1):135-142.

[80] Winklhofer KF;Haass C .Mitochondrial dysfunction in Parkinson's disease.[J].Biochimica et biophysica acta. Molecular basis of disease,2010(1):29-44.

[81] Shi P;Wei Y;Zhang J;Gal J;Zhu H .Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.[J].Journal of Alzheimer's disease,2010(suppl.2):S311-324.

[82] Santos RX;Correia SC;Wang X;Perry G;Smith MA;Moreira PI;Zhu X .A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.[J].Journal of Alzheimer's disease,2010(suppl.2):S401-412.

[83] Manczak,M.;Reddy,P.H. .Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: Implications for mitochondrial dysfunction and neuronal damage[J].Human Molecular Genetics,2012(11):2538-2547.

[84] Reddy PH.Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.[J].Brain research,2011:136-148.

[85] Silva DF;Esteves AR;Oliveira CR;Cardoso SM .Mitochondria: the common upstream driver of abeta and tau pathology in Alzheimer's disease.[J].Current Alzheimer research,2011(5):563-572.

[86] Chan DC .Mitochondrial dynamics in disease.[J].The New England journal of medicine,2007(17):1707-1709.

[91] Yonashiro R;Ishido S;Kyo S;Fukuda T;Goto E;Matsuki Y;Ohmura-Hoshino M;Sada K;Hotta H;Yamamura H .A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics[J].EMBO Journal,2006(15):3618-3626.

[92] Nakamura N;Kimura Y;Tokuda M;Honda S;Hirose S .MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology[J].EMBO Journal,2006(10):1019-1022.

[93] Karbowski M;Neutzner A;Youle RJ .The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division[J].The Journal of Cell Biology,2007(1):71-84.

[94] Santel A;Fuller MT .Control of mitochondrial morphology by a human mitofusin.[J].Journal of Cell Science,2001(Pt.5):867-874.

[95] Ishihara N;Eura Y;Mihara K .Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity.[J].Journal of Cell Science,2004(Pt.26):6535-6546.

[96] Cipolat S;Martins de Brito O;Dal Zilio B;Scorrano L .OPA1 requires mitofusin 1 to promote mitochondrial fusion.[J].Proceedings of the National Academy of Sciences of the United States of America,2004(45):15927-15932.

[98] Olichon A;Baricault L;Gas N;Guillou E;Valette A;Belenguer P;Lenaers G .Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.[J].The Journal of biological chemistry,2003(10):7743-7746.

[99] DuBoff,B.;G?tz,J.;Feany,M.B. .Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo[J].Neuron,2012(4):618-632.

[101] Alonso AD;Di Clerico J;Li B;Corbo CP;Alaniz ME;Grundke Iqbal I;Iqbal K .Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration.[J].The Journal of biological chemistry,2010(40):30851-30860.

[103] Goldbaum O;Richter Landsberg C .Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture.[J].The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,2004(25):5748-5757.

[104] Kopeikina KJ;Carlson GA;Pitstick R;Ludvigson AE;Peters A;Luebke JI;Koffie RM;Frosch MP;Hyman BT;Spires Jones TL .Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.[J].American Journal of Pathology: Official Publication of the American Association of Pathologists,2011(4):2071-2082.

[105] Rhein, V;Song, XM;Wiesner, A;Ittner, LM;Baysang, G;Meier, F;Ozmen, L;Bluethmann, H;Drose, S;Brandt, U;Savaskan, E;Czech, C;Gotz, J;Eckert, A .Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice[J].Proceedings of the National Academy of Sciences of the United States of America,2009(47):20057-20062.

[106] Thies E;Mandelkow EM .Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.[J].The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,2007(11):2896-2907.

[108] Stowers RS;Megeath LJ;Gorska Andrzejak J;Meinertzhagen IA;Schwarz TL .Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein.[J].Neuron,2002(6):1063-1077.

[109] Stamer K;Vogel R;Thies E;Mandelkow E;Mandelkow EM .Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.[J].The Journal of Cell Biology,2002(6):1051-1063.

[110] Shahpasand,K.;Uemura,I.;Saito,T.;Asano,T.;Hata,K.;Shibata,K.;Toyoshima,Y.;Hasegawa,M.;Hisanaga,S.-I. .Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease[J].The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,2012(7):2430-2441.

[112] Calcul,L.;Zhang,B.;Jinwal,U.K.;Dickey,C.A.;Baker,B.J. .Natural products as a rich source of tau-targeting drugs for Alzheimers disease[J].Future medicinal chemistry,2012(13):1751-1761.

[114] Orr GA;Verdier Pinard P;McDaid H;Horwitz SB .Mechanisms of Taxol resistance related to microtubules.[J].Oncogene,2003(47):7280-7295.

[118] Esteves,A.R.;Gozes,I.;Cardoso,S.M. .The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease[J].Biochimica et biophysica acta. Molecular basis of disease: BBA,2014(1):7-21.

[119] Jouroukhin,Y.;Ostritsky,R.;Assaf,Y.;Pelled,G.;Giladi,E.;Gozes,I..NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport[J].Neurobiology of disease,2013:79-94.

[120] Alam MI;Beg S;Samad A;Baboota S;Kohli K;Ali J;Ahuja A;Akbar M .Strategy for effective brain drug delivery.[J].European journal of pharmaceutical sciences,2010(5):385-403.

[121] Shytle,R.D.;Tan,J.;Bickford,P.C.;Rezai-Zadeh,K.;Hou,L.;Zeng,J.;Sanberg,P.R.;Sanberg,C.D.;Alberte,R.S.;Fink,R.C.;RoschekJr.,B. .Optimized turmeric extract reduces β-amyloid and phosphorylated Tau protein burden in Alzheimer's transgenic mice[J].Current Alzheimer research,2012(4):500-506.

[123] Rezai-Zadeh K;Arendash GW;Hou H;Fernandez F;Jensen M;Runfeldt M;Shytle RD;Tan J .Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.[J].Brain research,2008(0):177-187.

[125] Alejandra del C. Alonso;Inge Grundke-Iqbal;Hector S. Barra .Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau[J].Proceedings of the National Academy of Sciences of the United States of America,1997(1):298-303.

[126] Beharry,C.;Alaniz,M.E.;Alonso,A.D.C. .Expression of alzheimer-like pathological human tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster[J].Journal of Alzheimer's disease: JAD,2013(3):539-550.

DOI: http://dx.doi.org/10.1007/s12264-013-1414-z

语种: 英文   

基金Studies in our laboratories were supported in part by an N...

  • + 更多
  • 字体大小